Literature DB >> 26220009

Characterisation of novel RUNX2 mutation with alanine tract expansion from Japanese cleidocranial dysplasia patient.

Akio Shibata1, Junichiro Machida2, Seishi Yamaguchi3, Masashi Kimura4, Tadashi Tatematsu5, Hitoshi Miyachi6, Masaki Matsushita7, Hiroshi Kitoh7, Naoki Ishiguro7, Atsuo Nakayama8, Yujiro Higashi9, Kazuo Shimozato6, Yoshihito Tokita10.   

Abstract

Cleidocranial dysplasia (CCD; MIM 119600) is an autosomal dominant skeletal dysplasia characterised by hypopalstic and/or aplastic clavicles, midface hypoplasia, absent or delayed closure of cranial sutures, moderately short stature, delayed eruption of permanent dentition and supernumerary teeth. The molecular pathogenesis can be explained in about two-thirds of CCD patients by haploinsufficiency of the RUNX2 gene. In our current study, we identified a novel and rare variant of the RUNX2 gene (c.181_189dupGCGGCGGCT) in a Japanese patient with phenotypic features of CCD. The insertion led an alanine tripeptide expansion (+3Ala) in the polyalanine tract. To date, a RUNX2 variant with alanine decapeptide expansion (+10Ala) is the only example of a causative variant of RUNX2 with polyalanine tract expansion to be reported, whilst RUNX2 (+1Ala) has been isolated from the healthy population. Thus, precise analyses of the RUNX2 (+3Ala) variant were needed to clarify whether the tripeptide expanded RUNX2 is a second disease-causing mutant with alanine tract expansion. We therefore investigated the biochemical properties of the mutant RUNX2 (+3Ala), which contains 20 alanine residues in the polyalanine tract. When transfected in COS7 cells, RUNX2 (+3Ala) formed intracellular ubiquitinated aggregates after 24h, and exerted a dominant negative effect in vitro. At 24h after gene transfection, whereas slight reduction was observed in RUNX2 (+10Ala), all of these mutants significantly activated osteoblast-specific element-2, a cis-acting sequence in the promoter of the RUNX2 target gene osteocalcin. The aggregation growth of RUNX2 (+3Ala) was clearly lower and slower than that of RUNX2 (+10Ala). Furthermore, we investigated several other RUNX2 variants with various alanine tract lengths, and found that the threshold for aggregation may be RUNX2 (+3Ala). We conclude that RUNX2 (+3Ala) is the cause of CCD in our current case, and that the accumulation of intracellular aggregates in vitro is related to the length of the alanine tract.
© The Author 2015. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26220009     DOI: 10.1093/mutage/gev057

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  7 in total

1.  Syringic acid, a phenolic acid, promotes osteoblast differentiation by stimulation of Runx2 expression and targeting of Smad7 by miR-21 in mouse mesenchymal stem cells.

Authors:  B Arumugam; K Balagangadharan; N Selvamurugan
Journal:  J Cell Commun Signal       Date:  2018-01-19       Impact factor: 5.782

2.  Odontogenesis-Associated Phosphoprotein (ODAPH) Overexpression in Ameloblasts Disrupts Enamel Formation via Inducing Abnormal Mineralization of Enamel in Secretory Stage.

Authors:  Haiyu Mu; Zhiheng Dong; Yumin Wang; Qing Chu; Yan Gao; Aiqin Wang; Yu Wang; Xiaoying Liu; Yuguang Gao
Journal:  Calcif Tissue Int       Date:  2022-09-26       Impact factor: 4.000

3.  Novel Mutation of Cleidocranial Dysplasia-related Frameshift Runt-related Transcription Factor 2 in a Sporadic Chinese Case.

Authors:  Xue-Yan Qin; Pei-Zeng Jia; Hua-Xiang Zhao; Wei-Ran Li; Feng Chen; Jiu-Xiang Lin
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

Review 4.  A limb-girdle myopathy phenotype of RUNX2 mutation in a patient with cleidocranial dysplasia: a case study and literature review.

Authors:  Sung-Ju Hsueh; Ni-Chung Lee; Shu-Hua Yang; Han-I Lin; Chin-Hsien Lin
Journal:  BMC Neurol       Date:  2017-01-06       Impact factor: 2.474

Review 5.  Intrinsic Disorder in Proteins with Pathogenic Repeat Expansions.

Authors:  April L Darling; Vladimir N Uversky
Journal:  Molecules       Date:  2017-11-24       Impact factor: 4.411

6.  Whole-exome sequencing of a novel initiation codon mutation in RUNX2 in a Chinese family with cleidocranial dysplasia.

Authors:  Liyuan Yang; Genqi Lu; Wenjing Shen; Wenjing Chen; Haiyan Lu; Guozhong Zhang; Shuo Yuan; Shushen Zheng; Jiabao Ren
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

7.  Interpreting short tandem repeat variations in humans using mutational constraint.

Authors:  Melissa Gymrek; Thomas Willems; David Reich; Yaniv Erlich
Journal:  Nat Genet       Date:  2017-09-11       Impact factor: 38.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.